"Comparative evaluation of immunogenicity of bivalent oral poliovirus vaccine (bOPV) and monovalent oral poliovirus vaccine type 1 (mOPV1) when administered in the EPI schedule with a dose of inactivated polio vaccine (IPV) at week 14 and assessment of immunogenicity of IPV only schedule in the EPI: A multicentric open label randomized controlled trial" - WHO mOPV1 study
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Poliovirus vaccine inactivated (Primary) ; Poliovirus vaccine live oral (Primary) ; Poliovirus vaccine
- Indications Poliomyelitis
- Focus Pharmacodynamics
- Sponsors Panacea Biotec
- 08 Sep 2016 New trial record